The reappraisal of nephrocalcin - Its role in the inhibition of calcium oxalate crystal growth and interaction with divalent metal ions

Urological Research

Volumn 29, Issue 2, 2001, Pages 89-93

  Chang, Li Chi ^a   Lin, Her Sheng ^a   Chen, Wen Chi ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Calcium oxalate monohydrate; Crystallization; Metal ion; Nephrocalcin; Urolithiasis

Indexed keywords

ASCORBIC ACID; BILIRUBIN DERIVATIVE; CALCIUM; CALCIUM OXALATE; COPPER ION; GLYCOPROTEIN; METAL ION; NEPHROCALCIN; UNCLASSIFIED DRUG; WHEWELLITE;

ARTICLE; BINDING AFFINITY; CHEMICAL INTERACTION; CRYSTALLIZATION; GLYCOSYLATION; MOLECULAR WEIGHT; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN PROCESSING; STONE FORMATION; UROLITHIASIS;

ADULT; CALCIUM OXALATE; CRYSTALLIZATION; DRUG INTERACTIONS; GLYCOPROTEINS; HUMANS; IONS; MALE;

EID: 0035023020     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400000164     Document Type: Article

References (20)

1. Quantitative aspects of ascorbic acid metabolism in man
2. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis
3. Intake of vitamins B6 and C and the risk of kidney stones in women
4. Analysis of calcium, iron, copper and zinc contents of nucleus and crust parts of urinary calculi
5. Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine
6. Hypercalciuria and nephrocalcinosis, a feature of Wilson's disease
7. Biological oxidations, electron transport and oxidative phosphorylation
8. Trace metal-citric acid complexes as inhibitors of calcification and crystal growth. II. Effects of Fe(III), Cr(III) and Al(III) complexes on calcium oxalate crystal growth
9. 2+-binding sites in the kidney stone inhibitor glycoprotein nephrocalcin using vanadyl ions: Different metal binding properties in strong and weak inhibitor proteins revealed by EPR and ENDOR
10. Properties and function of nephrocalcin: Mechanism of kidney stone inhibition or promotion
11. Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium
12. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine
13. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficent in -carboxyglutamic acid
14. Elucidation of multiple forms of nephrocalcin by 31P-NMR spectrometer
15. Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation
16. Ascorbic acid in idiopathic recurrent calcium urolithiasis in humans - Does it have an abettor role in oxalate, and calcium oxalate crystallization?
17. Growth studies of calcium oxalate in the presence of various ions and compounds
18. Is nephrocalcin related to the urinary derivative (bikunin) of inter-trypsin inhibitor?
19. The effects of citrate and urine on calcium oxalate crystal aggregation
20. Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein